Clinical Trials for Triple Negative Breast Cancer

Find clinical trials for triple negative breast cancer. Discover research opportunities and treatment options in your area.

159 Active Trials Found

Showing 159 trials on this page

Page 3 of 8

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

NCT ID: NCT05633654

The ASCENT-05 clinical trial is studying a new treatment approach for patients with triple negative breast cancer (TNBC) who still have cancer remaining after surgery and previous therapy. This tri...

Recruiting

Phase: PHASE3 Type: interventional Locations: Worcester, Massachusetts, United States, Sacramento, California, United States +198 more

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

NCT ID: NCT05528133

This clinical trial is studying a new approach called genomically guided radiation therapy for people with triple negative breast cancer, which is a type of cancer that does not have certain hormon...

Recruiting

Phase: PHASE2 Type: interventional Locations: Tampa, Florida, United States, Clearwater, Florida, United States

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

NCT ID: NCT06586957

This clinical trial is studying a new treatment called NKT3964 for adults with advanced or metastatic solid tumors, which are cancers that have spread beyond their original location. The trial aims...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Nashville, Tennessee, United States +6 more

Study of Screening Brain MRIs in Stage IV Breast Cancer

NCT ID: NCT05115474

This clinical trial is studying the use of brain MRI scans to check for any potential issues in patients with advanced breast cancer who do not have any neurological symptoms. Specifically, it look...

Recruiting

Type: observational Locations: Tampa, Florida, United States, Clearwater, Florida, United States

A Phase I/II Study of VLS-1488 in Subjects With Advanced Cancer

NCT ID: NCT05902988

This clinical trial is studying a new treatment called VLS-1488 for people with advanced cancers, including types like ovarian, lung, breast, and colorectal cancer. The goal is to find out how safe...

Recruiting

Phase: PHASE1 Type: interventional Locations: Los Angeles, California, United States, Ann Arbor, Michigan, United States +12 more

Viscum Album for TNBC on Adjuvant Pembrolizumab

NCT ID: NCT06920810

This clinical trial is studying a treatment for adults with triple-negative breast cancer (TNBC) who have already had surgery. The researchers want to see if adding a natural extract called Viscum ...

Recruiting

Phase: PHASE4 Type: interventional Locations: Goyang Si, Gyeonggi Do, Korea, Republic Of

PRE-I-SPY Phase I/Ib Oncology Platform Program

NCT ID: NCT05868226

The PRE-I-SPY trial is a research study designed to test new treatments for various types of breast cancer, including HER2-positive and triple-negative breast cancer. The goal of this trial is to f...

Recruiting

Phase: PHASE1 Type: interventional Locations: Tampa, Florida, United States, Houston, Texas, United States +5 more

A Dose Randomization Study of Bulumtatug Fuvedotin in TNBC Patients Previously Treated With ADCs

NCT ID: NCT06908928

This clinical trial is investigating a new treatment called bulumtatug fuvedotin for patients with triple-negative breast cancer (TNBC) who have already received certain types of therapies. The pur...

Not yet recruiting

Phase: PHASE1 Type: interventional

A Study to Evaluate the Efficacy and Safety of Nanosomal Docetaxel Lipid Suspension in Triple Negative Breast Cancer Patients

NCT ID: NCT03671044

This clinical trial is studying a new treatment called Nanosomal Docetaxel Lipid Suspension (NDLS) for women with triple-negative breast cancer, which is a type of breast cancer that does not have ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Canton, Ohio, United States, Springfield, Missouri, United States +2 more

Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer

NCT ID: NCT04768426

This clinical trial is looking at a new way to help doctors understand how well a treatment called capecitabine works for patients with early-stage triple-negative breast cancer (TNBC). The study w...

Recruiting

Phase: PHASE2 Type: interventional Locations: Stanford, California, United States

A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.

NCT ID: NCT06022029

This clinical trial is studying a new treatment called ONM-501, which can be given alone or combined with another medication called cemiplimab, for patients with advanced solid tumors and lymphomas...

Recruiting

Phase: PHASE1 Type: interventional Locations: Columbus, Ohio, United States, Dallas, Texas, United States +14 more

Study of the Monoclonal Antibody IMT-009 in Patients with Advanced Solid Tumors or Lymphomas

NCT ID: NCT05565417

This clinical trial is studying a new treatment called IMT-009, which is a monoclonal antibody being given to patients with advanced cancers, including types like non-small cell lung cancer, breast...

Recruiting

Phase: PHASE1 Type: interventional Locations: Denver, Colorado, United States, Sarasota, Florida, United States +11 more

Novel Neoadjuvant and Adjuvant Strategy for Germline BRCA 1/2 Mutated Triple Negative Breast Cancer

NCT ID: NCT05485766

This clinical trial is studying a new treatment approach for patients with triple negative breast cancer (TNBC) who have specific gene mutations known as BRCA1 or BRCA2. The researchers want to see...

Recruiting

Phase: PHASE2 Type: interventional Locations: Gifu, , Japan, Tokyo, , Japan +2 more

SOC Chemotherapy +/- Tocilizumab for Triple Negative and ER-low Breast Cancers

NCT ID: NCT05846789

This clinical trial is looking at the effectiveness of a chemotherapy drug called carboplatin, both on its own and when combined with another medication called tocilizumab, for patients with metast...

Recruiting

Phase: PHASE2 Type: interventional Locations: Indianapolis, Indiana, United States, Indianapolis, Indiana, United States +2 more

Study of Autologous CAR-T Cells Targeting B7-H3 in TNBC iC9-CAR.B7-H3 T Cells

NCT ID: NCT06347068

This clinical trial is looking at a new treatment for patients with a specific type of breast cancer called triple-negative breast cancer (TNBC), which can be hard to treat. The study is testing a ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Chapel Hill, North Carolina, United States

Radiological Prediction of Response to Neoadjuvant Chemoimmunotherapy for Triple-negative Breast Cancer

NCT ID: NCT06879704

This clinical trial is looking at ways to predict how well patients with triple-negative breast cancer will respond to a combination of chemotherapy and immunotherapy before they start treatment. R...

Not yet recruiting

Phase: NA Type: interventional Locations: Rouen, , France

Naptumomab Estafenatox in Combination with Durvalumab in Subjects with Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

NCT ID: NCT03983954

This clinical trial is investigating a new treatment approach for patients with advanced or metastatic solid tumors, including types of cancer such as breast, ovarian, pancreatic, and esophageal ca...

Recruiting

Phase: PHASE1 Type: interventional Locations: Ramat Gan, , Israel, Petah Tikva, , Israel +7 more

A Multicenter Cancer Biospecimen Collection Study

NCT ID: NCT04510129

This clinical trial is focused on collecting tumor samples from patients with specific types of cancer, including head and neck, lung, and breast cancers, among others. The goal is to gather these ...

Recruiting

Type: observational Locations: San Francisco, California, United States

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Select Advanced Solid Tumor Indications Receiving Intravenous (IV) ABBV-400

NCT ID: NCT06084481

This clinical trial is studying a new treatment called ABBV-400 for adults with advanced solid tumors, such as liver cancer, pancreatic cancer, and certain types of breast and ovarian cancers. The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Grand Rapids, Michigan, United States, Durham, North Carolina, United States +64 more

NUC-3373 in Combination With Other Agents in Patients With Advanced Solid Tumours

NCT ID: NCT05714553

This clinical trial is investigating a new treatment called NUC-3373, which will be tested in combination with other medications to see how safe and effective it is for patients with advanced solid...

Recruiting

Phase: PHASE1 Type: interventional Locations: Manchester, , United Kingdom, London, , United Kingdom +2 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions